About Isogenica
Isogenica was a biotechnology company that specialized in protein engineering and synthetic biology platforms for pharmaceutical and biotechnology applications. The company developed proprietary technologies for protein discovery, optimization, and production, serving both internal drug development programs and external pharmaceutical partners. Isogenica's platforms enabled the rapid discovery and development of novel therapeutic proteins, including antibodies and other biologics, with applications across various disease areas.
Frequently Asked Questions
What does Isogenica do?
Biotechnology company developing protein engineering and synthetic biology platforms for drug discovery and development.
When was Isogenica founded?
Isogenica was founded in 2000 and is headquartered in Cambridge, UK.
What sector is Isogenica in?
Isogenica operates in the Biotech sector. Biotechnology company developing protein engineering and synthetic biology platforms for drug discovery and development.
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Company Details
- Sector
- Biotech
- Headquarters
- Cambridge, UK
- Founded
- 2000
- Status
- Active
